Adjuvant immunotherapy in colorectal cancer

Seminars in Oncology

Volumn 27, Issue 5 SUPPL. 10, 2000, Pages 66-71

  Vermorken, J B ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CANCER VACCINE; EDRECOLOMAB; FLUOROURACIL; GAMMA INTERFERON; LEVAMISOLE; PICIBANIL;

CANCER IMMUNOTHERAPY; CANCER MORTALITY; CHILL; CLINICAL TRIAL; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEVER; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETHARGY; MAJOR CLINICAL STUDY; META ANALYSIS; MYALGIA; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SURVIVAL RATE;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, MONOCLONAL; BCG VACCINE; CLINICAL TRIALS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY, ACTIVE; LEVAMISOLE;

EID: 0033786370     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Current controversies in cancer: Is there a standard adjuvant treatment for colon cancer?
2. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
3. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
4. Controlled trials of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
5. Fluorouracil (FU), leucovorin (LV) and levamisole adjuvant therapy for colon cancer: Five year final report of NT-0089
6. An overview of adjuvant therapy for colorectal cancer
7. Principles of cancer management: Biologic therapy
8. Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01
9. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil
10. Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trial
11. Controlled clinical trial of interferon-γ as postoperative surgical adjuvant therapy for colon cancer
12. Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjuvant to surgery
13. Active specific immunotherapy of residual micrometastases: An evaluation of sources, doses and ratios of BCG with tumor cells
14. Preparation of immunotherapeutic autologous vaccines from solid tumors
15. Active-specific immunotherapy of established metastases: Effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs
16. Therapy of spontaneous metastases by an autologous tumor vaccine
17. Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer
18. Adjuvant active specific immunotherapy for human colorectal cancer - 6.5 Year median follow-up of a phase III prospectively randomized trial
19. Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with a autologous tumor cell: Bacillus Calmette Guerin vaccine
20. Survival and relapse in adjuvant autologous tumor vaccine therapy for Dukes B and C colon cancer - EST 5283
21. Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
22. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-1, C-02, C-03, and C-04)
23. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer
24. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
25. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial